Cost-effectiveness of an individualised management program after stroke: a trial-based economic evaluation
Zhomart Orman,Muideen T Olaiya,Amanda G Thrift,Dominique A Cadilhac,Thanh Phan,Mark R Nelson,David Ung,Velandai K Srikanth,Christopher F Bladin,Richard P Gerraty,Joseph Phillipos,Joosup Kim,Muideen T. Olaiya,Amanda G. Thrift,Dominique A. Cadilhac,Mark R. Nelson,Velandai K. Srikanth,Christopher F. Bladin,Richard P. Gerraty
DOI: https://doi.org/10.1159/000535638
2024-02-15
Neuroepidemiology
Abstract:Introduction: Evidence on the cost-effectiveness of comprehensive post-stroke programs is limited. We assessed the cost-effectiveness of an individualised management program (IMP) for stroke or transient ischaemic attack (TIA). Methods: A cost-utility analysis alongside a randomised controlled trial with a 2-year follow-up, from both societal and health system perspectives, was conducted. Adults with stroke/TIA discharged from hospitals were randomised by primary care practice to receive either usual care (UC) or an IMP in addition to UC. An IMP included at-home stroke-specific nurse-led education and a specialist review of care plans at baseline, 3, and 12 months, and telephone reviews by nurses at 6 and 18 months. Costs in 2021 Australian dollars (AUD) and quality-adjusted life years (QALYs) were discounted by 5%. The probability of cost-effectiveness of the intervention was determined by quantifying 10,000 bootstrapped iterations of incremental costs and QALYs below the threshold of AUD50,000/QALY. Results: Among the 502 participants (65% male, median age 69 years), 251 (50%) were in the intervention group. From a health system perspective, the incremental cost per QALY gained was AUD53,175 with an IMP compared to UC alone. At a willingness-to-pay threshold of AUD50,000/QALY, an IMP was preferred in 46.7% of iterations. From a societal perspective, the intervention was dominant in 52.7% of iterations with mean per-patient costs of AUD49,045 and 1.352 QALYs compared to mean per-patient costs of AUD51,394 and 1.324 QALYs in the UC group. The probability of cost-effectiveness of an IMP, from a societal perspective, was 60.5%. Conclusions: Care for people with stroke/TIA using an IMP was cost-effective from a societal perspective over two years. Economic evaluations of prevention programs need sufficient time horizons and consideration of costs beyond direct health care utilisation to demonstrate their value to society.
public, environmental & occupational health,clinical neurology